Advanced Search

Home > Journals > Otorinolaringologia > Past Issues > Otorinolaringologia 2014 December;64(4) > Otorinolaringologia 2014 December;64(4):163-6

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEOTORINOLARINGOLOGIA

A Journal on Otorhinolaryngology, Head and Neck Surgery,
Plastic Reconstructive Surgery, Otoneurosurgery


Indexed/Abstracted in: EMBASE, Scopus

 

Otorinolaringologia 2014 December;64(4):163-6

COCHLEAR IMPLANTS AND OTHER IMPLANTABLE AUDITORY 

Nanoparticles as a drug-delivery vehicle for the inner ear

Kim M.-S., Kim D.-K.

Department of Otolaryngology, Head and Neck Surgery, Catholic University of Korea, College of Medicine, Seoul, Republic of Korea

Hearing loss is a common sequela to many inner ear disorders. However, the therapeutic options for these conditions are limited as the inner ear is inaccessible to many drugs. Theoretically, nanoparticles that permeate the round window can target specific cell populations and provide controlled drug release. Nanoparticles have shown promise as an inner ear drug delivery vehicle in many reports. Toxicity, especially with long-term use, should be determined prior to clinical use. Also, the drug to nanoparticle loading ratio should be increased to maximize the delivery efficacy and minimize toxic effects. Understanding of the RW, including the mechanism of passage, should be expanded.

language: English


FULL TEXT  REPRINTS

top of page